Analyst Reco. Sanofi

Equities

Real-time Euronext Paris Other stock markets 09:36:13 2025-02-10 am EST			5-day change	1st Jan Change
103.96 ^EUR	+0.58%		-0.42%	+10.97%

04:36am	Sanofi: L'Oréal below 15% of votes	CF
Feb. 07	Engie Signs 6-Year Structuring Contract With Sanofi	RE

Sanofi: analysts raise their targets	Feb. 03	CF
SANOFI : Receives a Buy rating from UBS	Feb. 03	ZD
SANOFI : price target raised at Barclays	Jan. 31	CF
SANOFI : Raised to Buy by DZ Bank	Jan. 31	ZD
SANOFI : Deutsche Bank no longer a seller	Jan. 31	CF
SANOFI : UBS keeps its Buy rating	Jan. 31	ZD
SANOFI : Deutsche Bank from Sell to Neutral	Jan. 31	ZD
SANOFI : 2024 targets achieved; markets appreciated shareholder rewards	Jan. 30
SANOFI : Bernstein reaffirms its Buy rating	Jan. 30	ZD
SANOFI : JP Morgan is Neutral	Jan. 30	ZD
SANOFI : Gets a Buy rating from UBS	Jan. 30	ZD
SANOFI : JP Morgan reaffirms its Neutral rating	Jan. 24	ZD
Sanofi: UBS reiterates its buy recommendation	Jan. 23	CF
SANOFI : UBS reiterates its buy recommendation	Jan. 23	CF
SANOFI : Gets a Buy rating from UBS	Jan. 23	ZD
SANOFI : JP Morgan gives a Neutral rating	Jan. 16	ZD
SANOFI : Gets a Buy rating from Berenberg	Jan. 07	ZD
SANOFI : Bernstein reiterates its Buy rating	Jan. 07	ZD
AlphaValue/Baader Europe Downgrades Sanofi to Add, Lifts PT	Dec. 30	MT
AlphaValue/Baader Europe Trims Sanofi PT, Reiterates Buy Rating	Dec. 25	MT
SANOFI : Innovative pharmaceutical business to remain in the spotlight in 2025	Dec. 24
SANOFI : Oddo BHF confirms its recommendation on the stock	Dec. 18	CF
SANOFI : Receives a Sell rating from Deutsche Bank	Dec. 18	ZD
SANOFI : Jefferies gives a Buy rating	Dec. 17	ZD
SANOFI : JP Morgan remains Neutral	Dec. 17	ZD

No results for this search

SANOFI : 2024 targets achieved; markets appreciated shareholder rewards

January 30, 2025 at 02:32 pm EST

Sanofi : The Doliprane case

October 18, 2024 at 09:16 am EDT

Paul Hudson, CEO of Sanofi: AI to improve organisational efficiency